Bakuchi for Antimicrobial Properties

Research suggests that bakuchi and its primary bioactive compound bakuchiol demonstrate notable antimicrobial properties across a range of pathogens, including gram-positive bacteria such as Staphylococcus aureus and MRSA, gram-negative bacteria such as Acinetobacter baumannii, fungi such as Candida albicans, and mycobacterial species, with some studies reporting minimum inhibitory concentrations in the low microgram-per-milliliter range. Studies indicate that proposed mechanisms include disruption of bacterial cell membranes and phospholipid targeting, and several investigations have explored bakuchiol derivatives and formulations such as nanoemulsions as strategies to enhance efficacy. The current body of evidence consists primarily of laboratory-based in vitro studies, preclinical investigations, and narrative reviews rather than clinical trials in humans, which is a meaningful limitation when considering how these findings might translate to real-world applications. Flavonoid constituents of Psoralea corylifolia, the plant source of bakuchi, such as isobavachalcone and prenylated flavonoids, have also independently shown antimicrobial activity in published literature, suggesting that the plant's overall antimicrobial profile may reflect contributions from multiple compounds rather than bakuchiol alone.